Hundreds contact BBC about mystery skin condition ‘hell’ – but doctors can’t agree it exists
Hundreds Contact BBC About ‘Hell’ Skin Condition, But Medical Experts Remain Divided
Two weeks ago, a BBC News article delved into a perplexing skin issue that has gained traction on social media, termed topical steroid withdrawal (TSW). While some view it as a severe eczema episode, others argue it represents a distinct condition. The lack of consensus among healthcare professionals has left patients seeking answers. The piece resonated with millions of readers, prompting over 240 individuals to share their experiences. Now, deeper exploration into the phenomenon reveals the complexity behind its persistence as an enigma.
The Patient’s Story
Bethany Norman, 36, described her ordeal as a personal battle against a condition she believes was caused by steroid creams. Her son, suffering from eczema, became the focal point of her resolve. Despite doctors’ recommendations, she refused to apply steroids, fearing the same outcome for her child. “Look at what this medication has done to me? Why would I put it on my own son?” she recalls shouting, her arms wrapped in bandages as she clutched her newborn. Her symptoms—open wounds, unrelenting itch, and continuous skin shedding—left her feeling trapped in her body. She saw no choice but to avoid the creams that had been central to her own eczema treatment.
“I’ve been told by countless medics that all I have is a severe flare up of eczema and steroid creams will sort it. They just made it worse.” – Bethany Norman
Medical Professionals’ Perspectives
Dr. Pippa Bowes, an urgent care physician in Southampton with expertise in acute dermatology, highlights the communication gap. “There can be a breakdown of trust,” she says, explaining how patients sometimes feel unheard, while some medical professionals struggle to grasp the condition’s nuances. Meanwhile, Jenna Crosbie, a trainee GP in north Wales, initially found Bethany’s decision puzzling. Her training had emphasized steroids as a primary treatment for eczema. Yet, after witnessing a TSW case in A&E, she began to question her own reliance on the creams.
“I remember thinking it looked like the most severe full-body eczema I’d ever seen, and I couldn’t understand why the patient was refusing steroids.” – Jenna Crosbie
Crosbie’s own experience with TSW emerged as she worked night shifts. She noticed her skin condition worsening despite using more topical steroids. Upon researching, she realized her symptoms diverged from typical eczema, prompting her to discontinue the creams. Her GP’s support allowed her to grasp the patient’s struggle, a realization she now conveys with empathy: “I wouldn’t wish it on my worst enemy.”
The Debate Over Treatment
Dr. Dean Eggit, a GP in Doncaster, raises concerns about steroid overuse. While acknowledging their importance, he notes that prescriptions may sometimes be misapplied. “GPs can often see a red rash and prescribe steroids without investigating further,” he says. This approach risks perpetuating TSW, as early signs can mirror the original eczema. “The beginnings of TSW can look like the original rash, making it hard to distinguish,” he explains.
The National Institute for Health and Clinical Excellence (NICE) advocates a progressive escalation and reduction strategy for eczema management. Starting with emollients, followed by lower-dose steroids, and adjusting potency as needed. Yet, without clear diagnostic criteria, TSW remains a contested topic. Doctors are left navigating uncertainty, balancing the efficacy of steroids with the growing number of patients reporting adverse effects.
With limited research and unresolved solutions, the divide between patients and practitioners continues. For many, the condition feels like an unacknowledged struggle, while for others, it underscores the need for more nuanced treatment approaches. As TSW gains attention, the hope is that deeper understanding will bridge the gap between medical expertise and patient experience.
